ホーム › 乳がん › アーカンソー州

アーカンソー州における乳がんの臨床試験

アーカンソー州内の拠点で、乳がんに関する17件の研究が参加者を募集しています。

アーカンソー州内の都市

公式研究テキスト（英語）

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

CARTI Cancer Center, Little Rock

被験者募集中第3相

18歳〜100歳 · 全性別 · 2026/10/02更新 · NCT05827081

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mercy Hospital Fort Smith, Fort Smith
CARTI Cancer Center, Little Rock

被験者募集中観察研究健康なボランティア歓迎

40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Research Site, Springdale

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/25更新 · NCT06103864

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Clinical Trial Site, Hot Springs

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/23更新 · NCT07085767

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Genesis Cancer and Blood Institute, Hot Springs
Highlands Oncology Group, Springdale

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/22更新 · NCT07174336

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Highlands Oncology Group, Springdale

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/17更新 · NCT07173751

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Highlands Oncology Group, PA, Springdale

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/15更新 · NCT06492616

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

Genesis Cancer and Blood Institute, Hot Springs

被験者募集中第1相

18歳〜55歳 · 女性 · 2026/09/09更新 · NCT07310420

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Mercy Hospital Fort Smith, Fort Smith
NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
Baptist Health Medical Center - Little Rock, Little Rock
他2件

被験者募集中第3相

18歳〜60歳 · 女性 · 2026/09/02更新 · NCT05879926

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

University of Arkansas for Medical Sciences, Little Rock

被験者募集中第3相

18歳以上 · 全性別 · 2026/08/17更新 · NCT06500481

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

Local Institution - 0303, Hot Springs

被験者募集中第2/3相

18歳以上 · 全性別 · 2026/08/10更新 · NCT06926868

E-Mindfulness Approaches for Living After Breast Cancer

Mercy Hospital Fort Smith, Fort Smith
NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
University of Arkansas for Medical Sciences, Little Rock

被験者募集中第3相

18歳〜50歳 · 全性別 · 2026/08/04更新 · NCT06748222